The present invention is directed to novel 3-benzoimidazolyl-pyrazolopyridine compounds of formula (I): ##STR00001## and pharmaceutically acceptable forms thereof and their synthesis and use as inhibitors of serine-threonine protein kinases and tyrosine protein kinases and interactions thereof.